Why the study?
Heart failure symptoms and health-related quality of life vary among subgroups, but evidence on the association between changing health-related quality of life and outcomes had not been evaluated.
Does the 6-month change in patient-reported symptoms and HRQoL predict 1-year mortality or HF hospitalization in heart failure patients across different sex, ethnicity, and socioeconomic status groups?
Does the 6-month change in patient-reported symptoms and HRQoL predict 1-year mortality or HF hospitalization in heart failure patients across different sex, ethnicity, and socioeconomic status groups?
Answers are grounded in this paper and cite their sources.
Serial measures of patient-reported symptoms and HRQoL are significant predictors of 1-year mortality or HF hospitalization in Asian patients with heart failure, offering a pragmatic approach to risk stratification.
Background: In heart failure (HF), symptoms and health-related quality of life (HRQoL) are known to vary among different HF subgroups, but evidence on the association between changing HRQoL and outcomes has not been evaluated. Objectives: The authors sought to investigate the relationship between changing symptoms, signs, and HRQoL and outcomes by sex, ethnicity, and socioeconomic status (SES). Methods: Using the ASIAN-HF (Asian Sudden Cardiac Death in Heart Failure) Registry, we investigated associations between the 6-month change in a "global" symptoms and signs score (GSSS), Kansas City Cardiomyopathy Questionnaire overall score (KCCQ-OS), and visual analogue scale (VAS) and 1-year mortality or HF hospitalization. Conclusions: Serial measures of patient-reported symptoms and HRQoL are significant and consistent predictors of outcomes among different groups with HF and provide the potential for a patient-centered and pragmatic approach to risk stratification.
No takes yet. Share an insight, caveat, or question.
Lawson et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: